Alios BioPharma Report issue

For profit Phase 1 Phase 2
Founded: South San Francisco CA United States (2006)
Status: Acquired by Johnson and Johnson (2014)

Organization Overview

First Clinical Trial
2011
NCT01590407
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Alios Biopharma | Alios Biopharma Inc.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hepatitis (Phase 2)

Hepatitis A (Phase 2)

Hepatitis B (Phase 2)

Hepatitis B, Chronic (Phase 2)

Hepatitis C (Phase 2)

Hepatitis C, Chronic (Phase 2)

Hepatitis, Chronic (Phase 2)

Infections (Phase 2)

Influenza, Human (Phase 1)

Respiratory Syncytial Virus Infections (Phase 2)

Virus Diseases (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 23
  • # of Trial APIs: 25